Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BMA vs GS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BMA
Banco Macro S.A.

Banks - Regional

Financial ServicesNYSE • AR
Market Cap$4.84B
5Y Perf.+348.5%
GS
The Goldman Sachs Group, Inc.

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$291.19B
5Y Perf.+377.0%

BMA vs GS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BMA logoBMA
GS logoGS
IndustryBanks - RegionalFinancial - Capital Markets
Market Cap$4.84B$291.19B
Revenue (TTM)$6.46T$126.85B
Net Income (TTM)$291.41B$16.67B
Gross Margin68.3%41.1%
Operating Margin5.6%14.5%
Forward P/E0.0x15.8x
Total Debt$465.41B$616.93B
Cash & Equiv.$2.78T$182.09B

BMA vs GSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BMA
GS
StockMay 20May 26Return
Banco Macro S.A. (BMA)100448.5+348.5%
The Goldman Sachs G… (GS)100477.0+377.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: BMA vs GS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GS leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Banco Macro S.A. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
BMA
Banco Macro S.A.
The Banking Pick

BMA is the clearest fit if your priority is valuation efficiency and bank quality.

  • PEG 0.00 vs GS's 1.13
  • NIM 11.1% vs GS's 0.5%
  • Lower P/E (0.0x vs 15.8x), PEG 0.00 vs 1.13
Best for: valuation efficiency and bank quality
GS
The Goldman Sachs Group, Inc.
The Banking Pick

GS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 12 yrs, beta 1.47, yield 1.4%
  • Rev growth 17.0%, EPS growth 77.3%
  • 5.4% 10Y total return vs BMA's 56.3%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthGS logoGS17.0% NII/revenue growth vs BMA's -33.3%
ValueBMA logoBMALower P/E (0.0x vs 15.8x), PEG 0.00 vs 1.13
Quality / MarginsGS logoGSEfficiency ratio 0.3% vs BMA's 0.6% (lower = leaner)
Stability / SafetyGS logoGSBeta 1.47 vs BMA's 1.76
DividendsBMA logoBMA6.8% yield, 1-year raise streak, vs GS's 1.4%
Momentum (1Y)GS logoGS+73.4% vs BMA's -6.5%
Efficiency (ROA)GS logoGSEfficiency ratio 0.3% vs BMA's 0.6%

BMA vs GS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BMABanco Macro S.A.

Segment breakdown not available.

GSThe Goldman Sachs Group, Inc.
FY 2024
Global Markets
65.3%$34.9B
Investment Management
30.2%$16.1B
Platform Solutions
4.5%$2.4B

BMA vs GS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBMALAGGINGGS

Income & Cash Flow (Last 12 Months)

GS leads this category, winning 3 of 5 comparable metrics.

BMA is the larger business by revenue, generating $6.46T annually — 51.0x GS's $126.9B. GS is the more profitable business, keeping 11.3% of every revenue dollar as net income compared to BMA's 5.0%.

MetricBMA logoBMABanco Macro S.A.GS logoGSThe Goldman Sachs…
RevenueTrailing 12 months$6.46T$126.9B
EBITDAEarnings before interest/tax$620.9B$23.4B
Net IncomeAfter-tax profit$291.4B$16.7B
Free Cash FlowCash after capex-$2.44T$15.8B
Gross MarginGross profit ÷ Revenue+68.3%+41.1%
Operating MarginEBIT ÷ Revenue+5.6%+14.5%
Net MarginNet income ÷ Revenue+5.0%+11.3%
FCF MarginFCF ÷ Revenue+12.3%-12.1%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-136.4%+45.8%
GS leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

BMA leads this category, winning 6 of 6 comparable metrics.

At 21.1x trailing earnings, BMA trades at a 9% valuation discount to GS's 23.1x P/E. Adjusting for growth (PEG ratio), BMA offers better value at 0.41x vs GS's 1.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricBMA logoBMABanco Macro S.A.GS logoGSThe Goldman Sachs…
Market CapShares × price$4.8B$291.2B
Enterprise ValueMkt cap + debt − cash$3.2B$726.0B
Trailing P/EPrice ÷ TTM EPS21.07x23.12x
Forward P/EPrice ÷ next-FY EPS est.0.01x15.84x
PEG RatioP/E ÷ EPS growth rate0.41x1.65x
EV / EBITDAEnterprise value multiple8.89x34.92x
Price / SalesMarket cap ÷ Revenue1.04x2.30x
Price / BookPrice ÷ Book value/share1.69x2.56x
Price / FCFMarket cap ÷ FCF8.49x
BMA leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

BMA leads this category, winning 7 of 9 comparable metrics.

GS delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $6 for BMA. BMA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), BMA scores 6/9 vs GS's 4/9, reflecting solid financial health.

MetricBMA logoBMABanco Macro S.A.GS logoGSThe Goldman Sachs…
ROE (TTM)Return on equity+6.1%+12.6%
ROA (TTM)Return on assets+1.4%+0.9%
ROICReturn on invested capital+5.5%+1.9%
ROCEReturn on capital employed+5.5%+3.6%
Piotroski ScoreFundamental quality 0–964
Debt / EquityFinancial leverage0.11x5.06x
Net DebtTotal debt minus cash-$2.31T$434.8B
Cash & Equiv.Liquid assets$2.78T$182.1B
Total DebtShort + long-term debt$465.4B$616.9B
Interest CoverageEBIT ÷ Interest expense0.28x0.31x
BMA leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — BMA and GS each lead in 3 of 6 comparable metrics.

A $10,000 investment in BMA five years ago would be worth $69,454 today (with dividends reinvested), compared to $27,109 for GS. Over the past 12 months, GS leads with a +73.4% total return vs BMA's -6.5%. The 3-year compound annual growth rate (CAGR) favors BMA at 70.7% vs GS's 44.0% — a key indicator of consistent wealth creation.

MetricBMA logoBMABanco Macro S.A.GS logoGSThe Goldman Sachs…
YTD ReturnYear-to-date-11.6%+3.0%
1-Year ReturnPast 12 months-6.5%+73.4%
3-Year ReturnCumulative with dividends+397.7%+198.7%
5-Year ReturnCumulative with dividends+594.5%+171.1%
10-Year ReturnCumulative with dividends+56.3%+536.1%
CAGR (3Y)Annualised 3-year return+70.7%+44.0%
Evenly matched — BMA and GS each lead in 3 of 6 comparable metrics.

Risk & Volatility

GS leads this category, winning 2 of 2 comparable metrics.

GS is the less volatile stock with a 1.47 beta — it tends to amplify market swings less than BMA's 1.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GS currently trades 95.2% from its 52-week high vs BMA's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBMA logoBMABanco Macro S.A.GS logoGSThe Goldman Sachs…
Beta (5Y)Sensitivity to S&P 5001.76x1.47x
52-Week HighHighest price in past year$106.15$984.70
52-Week LowLowest price in past year$38.30$547.06
% of 52W HighCurrent price vs 52-week peak+72.5%+95.2%
RSI (14)Momentum oscillator 0–10035.355.0
Avg Volume (50D)Average daily shares traded364K2.0M
GS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — BMA and GS each lead in 1 of 2 comparable metrics.

Wall Street rates BMA as "Buy" and GS as "Hold". Consensus price targets imply 68.9% upside for BMA (target: $130) vs 6.2% for GS (target: $996). For income investors, BMA offers the higher dividend yield at 6.81% vs GS's 1.44%.

MetricBMA logoBMABanco Macro S.A.GS logoGSThe Goldman Sachs…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$130.00$995.89
# AnalystsCovering analysts1455
Dividend YieldAnnual dividend ÷ price+6.8%+1.4%
Dividend StreakConsecutive years of raises112
Dividend / ShareAnnual DPS$7302.65$13.48
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.5%
Evenly matched — BMA and GS each lead in 1 of 2 comparable metrics.
Key Takeaway

GS leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). BMA leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.

Best OverallBanco Macro S.A. (BMA)Leads 2 of 6 categories
Loading custom metrics...

BMA vs GS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is BMA or GS a better buy right now?

For growth investors, The Goldman Sachs Group, Inc.

(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus -33. 3% for Banco Macro S. A. (BMA). Banco Macro S. A. (BMA) offers the better valuation at 21. 1x trailing P/E (0. 0x forward), making it the more compelling value choice. Analysts rate Banco Macro S. A. (BMA) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BMA or GS?

On trailing P/E, Banco Macro S.

A. (BMA) is the cheapest at 21. 1x versus The Goldman Sachs Group, Inc. at 23. 1x. On forward P/E, Banco Macro S. A. is actually cheaper at 0. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Banco Macro S. A. wins at 0. 00x versus The Goldman Sachs Group, Inc. 's 1. 13x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — BMA or GS?

Over the past 5 years, Banco Macro S.

A. (BMA) delivered a total return of +594. 5%, compared to +171. 1% for The Goldman Sachs Group, Inc. (GS). Over 10 years, the gap is even starker: GS returned +536. 1% versus BMA's +56. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BMA or GS?

By beta (market sensitivity over 5 years), The Goldman Sachs Group, Inc.

(GS) is the lower-risk stock at 1. 47β versus Banco Macro S. A. 's 1. 76β — meaning BMA is approximately 20% more volatile than GS relative to the S&P 500. On balance sheet safety, Banco Macro S. A. (BMA) carries a lower debt/equity ratio of 11% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — BMA or GS?

By revenue growth (latest reported year), The Goldman Sachs Group, Inc.

(GS) is pulling ahead at 17. 0% versus -33. 3% for Banco Macro S. A. (BMA). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to -44. 6% for Banco Macro S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BMA or GS?

The Goldman Sachs Group, Inc.

(GS) is the more profitable company, earning 11. 3% net margin versus 5. 0% for Banco Macro S. A. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GS leads at 14. 5% versus 5. 6% for BMA. At the gross margin level — before operating expenses — BMA leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BMA or GS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Banco Macro S. A. (BMA) is the more undervalued stock at a PEG of 0. 00x versus The Goldman Sachs Group, Inc. 's 1. 13x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Banco Macro S. A. (BMA) trades at 0. 0x forward P/E versus 15. 8x for The Goldman Sachs Group, Inc. — 15. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMA: 68. 9% to $130. 00.

08

Which pays a better dividend — BMA or GS?

All stocks in this comparison pay dividends.

Banco Macro S. A. (BMA) offers the highest yield at 6. 8%, versus 1. 4% for The Goldman Sachs Group, Inc. (GS).

09

Is BMA or GS better for a retirement portfolio?

For long-horizon retirement investors, The Goldman Sachs Group, Inc.

(GS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 4% yield, +536. 1% 10Y return). Banco Macro S. A. (BMA) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GS: +536. 1%, BMA: +56. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BMA and GS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BMA is a small-cap income-oriented stock; GS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BMA

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 2.7%
Run This Screen
Stocks Like

GS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BMA and GS on the metrics below

Revenue Growth>
%
(BMA: -33.3% · GS: 17.0%)
Net Margin>
%
(BMA: 5.0% · GS: 11.3%)
P/E Ratio<
x
(BMA: 21.1x · GS: 23.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.